DataMEDS AI Inc.
MEDS | NASDAQ
$1.86
-$0.06 (-3.12%)
Nov 2, 2026, 12:33 PM ET · Market open
TTM Period Ending | Q2 2026 Jun 30, 2026 | Q1 2026 Mar 31, 2026 | Q4 2025 Dec 31, 2025 | Q3 2025 Sep 30, 2025 | Q2 2025 Jun 30, 2025 | Q1 2025 Mar 31, 2025 | Q4 2024 Dec 31, 2024 | Q3 2024 Sep 30, 2024 | Q2 2024 Jun 30, 2024 | Q1 2024 Mar 31, 2024 | Q4 2023 Dec 31, 2023 | Q3 2023 Sep 30, 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Income | -88.28M | -76.59M | -101.27M | -77.75M | -45.3M | -39.2M | -13.41M | -10.15M | -9.19M | -8.62M | -1.98M | -903.31K |
Depreciation & Amortization | 4M | 2.77M | 3.21M | 3.06M | 2.71M | 1.92M | 1.12M | 475.73K | 21.1K | 8.3K | n/a | n/a |
Stock-Based Compensation | 28.65M | 28.38M | 54.79M | 54.44M | 28.71M | 27.77M | 24.27K | 24.27K | 24.27K | 24.27K | n/a | n/a |
Other Working Capital | 4.41M | 2.52M | 3.6M | 3.09M | 4.87M | 5.41M | -2.47M | -3.04M | -5.35M | -6.1M | 863.13K | 808K |
Other Non-Cash Items | 34.35M | 25.15M | 23.93M | 3.21M | 1.41M | 1.27M | 5.1M | 3.95M | 3.92M | 3.92M | n/a | n/a |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Change in Working Capital | 7.54M | 7.37M | 8.48M | 9.83M | 7.43M | 5.35M | -4.57M | -3.83M | -5.24M | -5.88M | 1.63M | 1.02M |
Operating Cash Flow | -13.74M | -12.92M | -10.86M | -7.22M | -5.05M | -2.89M | -11.73M | -9.54M | -10.46M | -10.54M | -349.12K | 112.94K |
Capital Expenditures | 149.68K | -187.35K | -255.38K | -112.44K | -734.55K | -602.63K | -329.49K | -217.05K | -4 | n/a | n/a | n/a |
Cash Acquisitions | n/a | n/a | n/a | 1M | 901.11K | 931.37K | 931.37K | -68.63K | 30.26K | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | -2.5M | -2.5M | -2.5M | -2.5M | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | -1.07M | -626.14K | -626.14K | -675.3K | -49.15K | -85.01K | 29.85M | 29.9M | 29.9M | 29.93M | n/a | n/a |
Investing Cash Flow | -923.7K | -813.49K | -881.53K | 212.27K | 117.41K | 195.94K | 27.9M | 27.06M | 27.38M | 27.43M | n/a | n/a |
Debt Repayment | 10.58M | 3.27M | -2.31M | -843.39K | 250.43K | 606.57K | 370.7K | -183.52K | 100K | 350K | 350K | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | -12.67M | -12.67M | -12.67M | -12.67M | n/a | n/a |
Other Financial Acitivies | 732.7K | 885.4K | 1.95M | 340.16K | 628.2K | 475.5K | 351.19K | -963.31K | -1.25M | -1.25M | n/a | n/a |
Financial Cash Flow | 16.7M | 11.27M | 10.75M | 10.44M | 5.28M | 4.92M | -12.09M | -13.79M | -13.8M | -13.55M | 350K | n/a |
Net Cash Flow | 2.04M | -2.46M | -985.77K | 3.44M | 352.97K | 2.22M | 4.08M | 3.74M | 3.12M | 3.35M | 884 | 112.94K |
Free Cash Flow | -13.59M | -13.11M | -11.11M | -7.33M | -5.78M | -3.49M | -12.06M | -9.75M | -10.46M | -10.54M | -349.12K | 112.94K |
Adj. Free Cash Flow | -42.23M | -41.49M | -65.9M | -61.77M | -34.49M | -31.27M | -12.09M | -9.78M | -10.49M | -10.56M | -349.12K | 112.94K |
Maintenance CapEx | -260.52K | -187.35K | -132.78K | 10.16K | -398.38K | -266.46K | -115.92K | -3.49K | n/a | n/a | n/a | n/a |
Growth CapEx | 410.2K | n/a | -122.6K | -122.6K | -336.16K | -336.17K | -213.57K | -213.57K | -4 | n/a | n/a | n/a |
Owner Earnings | -14M | -13.11M | -10.99M | -7.21M | -5.45M | -3.16M | -11.85M | -9.54M | -10.46M | n/a | n/a | n/a |
Add to Watchlist
Select watchlists to add or remove MEDS